For the Quarter Ending June 2025
North America
• The Magnesium Stearate Spot Price averaged USD 2240/MT in June 2025 and reflected a mild Q2 price erosion of 0.67%. The price fluctuation was driven by subdued demand and elevated inventory levels across nutraceutical and personal care segments.
• The Magnesium Stearate Price Forecast was conservative throughout Q2 as importers prioritized inventory liquidation over new procurements amid stagnant end-user offtakes.
• In April 2025, the Price Index saw a sharp decline of 7.11% that was attributed to lower Chinese export offers. This price drop was a result of drop in the prices of Stearic Acid, and reduced US orders due to tariffs.
• May showed slight price stabilization (0.31% uptick) as pharma and food fortification sectors engaged in safety stock procurement and balanced import volumes without triggering speculative demand.
• By June, steady Magnesium Stearate Production Cost Trends in origin markets ensured consistent overseas supply, despite freight rate volatility and demand-side lethargy in US consumption.
• Importers entered Q2 with substantial inventory buffers, allowing for restrained buying strategies and limited spot transactions, keeping the Magnesium Stearate Spot Price within a tight range.
• No logistical disruptions were reported across Q2, with port and inland operations functioning efficiently, mitigating supply-side risk and preventing upward pressure on landed costs.
• Downstream sectors, particularly OTC and wellness-based nutraceuticals, showed no promotional drivers or seasonal push, muting the Magnesium Stearate Demand Outlook.
• Why did the price change in July 2025? Exporters from key Asian hubs have adjusted their offers modestly to sustain market share but were unable to trigger any meaningful price rebound due to inventory overhang in the US.
Asia-Pacific
• The Magnesium Stearate Spot Price in June averaged USD 2120/MT, marking a marginal Q2 correction of 0.70% due to weak domestic and overseas downstream demand.
• The Magnesium Stearate Price Forecast remained flat-to-bearish across Q2, as both local and international buyers held off from forward orders amid routine offtake patterns.
• In April, falling Stearic Acid prices helped reduce the Magnesium Stearate Production Cost Trend, allowing suppliers to quote competitively despite stable output levels.
• May saw a minor 0.23% dip in the Price Index, shaped by cautious procurement and steady supply pipeline without any urgent restocking cues from foreign buyers.
• Exporters maintained regular shipment schedules with no port congestion or export curbs, ensuring that supply-side stability neutralized any upward pricing impulses.
• Elevated inventory levels by June, due to weak off-take in pharma and personal care segments, reinforced bearish sentiment in spot transactions.
• Despite stable production and feedstock pricing, the lack of seasonal demand surges or global promotional campaigns constrained the Magnesium Stearate Demand Outlook.
• Chinese suppliers avoided speculative pricing and focused on liquidity and inventory rotation, capping price movement within a narrow band throughout the quarter.
• Why did the price change in July 2025? The demand from health supplement and OTC product formulators abroad remained routine in early July 2025 with no major global events triggering bulk orders.
Europe
• European Magnesium Stearate Spot Prices likely trended slightly downward in Q2 2025, in line with global market sentiment and steady import flow from Asia-based suppliers.
• The Magnesium Stearate Price Forecast for Q2 was shaped by stable production at origin markets and weak seasonal triggers across EU-based pharma and personal care manufacturers.
• April likely saw softening in the Price Index, influenced by lower Asian offers and easing freight rates, especially from Chinese ports to key European entry points.
• Mid-quarter, consistent production cost control and absence of raw material price shocks contributed to a steady Magnesium Stearate Production Cost Trend, which discouraged price hikes.
• European buyers likely mirrored U.S. and APAC procurement behaviour—working through Q1 stockpiles rather than initiating aggressive restocking, keeping demand neutral.
• No reports of supply chain disruptions or port delays suggest that import costs remained under control, helping stabilize regional landed prices.
• Pharmaceutical and cosmetic sector offtake in Europe remained largely contract-based and tied to routine demand, with no visible uptick in Magnesium Stearate Demand Outlook.
• Buyers remained price-sensitive throughout Q2, especially given the strong euro and moderate energy input cost levels across the continent.
• Why did the price change in July 2025? Export quotations into Europe were stable-to-soft as global suppliers prioritized volume over margins in a tepid demand landscape in July 2025.
For the Quarter Ending March 2025
North America
In the first quarter of 2025 the prices of Magnesium Stearate in North America increased by an average of 11.68% compared to the previous quarter. The rise was mainly supported by improved demand from pharmaceutical and nutraceutical industries. Buyers showed strong interest as seasonal transition from winter to spring brought higher production activities across several sectors. Procurement remained active throughout the quarter.
Inventory levels were carefully managed by suppliers, which helped avoid sudden supply gaps. There were tariff changes during the quarter, but they did not have any significant impact on Magnesium Stearate prices. Supply conditions were smooth, and no major logistic bottlenecks were reported in North American region during first quarter of 2025.
Overall, higher usage in personal care and food-grade applications also supported the upward momentum. The positive sentiment in the domestic market coupled with anticipation of increased downstream production cycles contributed to price firmness. The combination of demand recovery and planned procurement made the first quarter fairly strong for Magnesium Stearate in the North American market.
Asia Pacific
Magnesium Stearate prices in Asia Pacific increased by an average of 7.87% from the previous quarter to the first quarter of 2025. This rise was a result of gradual improvement in demand across pharmaceutical and personal care industries. The increasing demand was supported by seasonal uptick in production activities and steady consumption patterns across end-user markets.
Strategic buying before the Chinese Lunar New Year contributed to the upward push in January. Post-holiday restocking by buyers in February and March kept consumption levels steady. Seasonal transition also played a part, as production in warmer months started picking up pace. Suppliers in key exporting regions maintained tight control over inventories, which limited supply availability at certain points during the quarter. Despite relatively stable costs of raw materials better export momentum helped support the overall price trend for the APAC region. Procurement remained smooth, and logistics faced no major challenges in the region. The general sentiment in the Asia Pacific market reflected healthy demand planning, and buyers remained focused on forward-looking needs. These combined factors led to a firm and gradual price increase for Magnesium Stearate throughout the first quarter of 2025.
Europe
In the first quarter of 2025, the price of Magnesium Stearate in Europe experienced a steady increase, aligning with global market trends. The pharmaceutical, nutraceutical and personal care sectors were key drivers of this rise, as demand in these industries remained strong. Strategic procurement practices and the effective management of inventory levels ensured a continuous supply, helping to avoid any significant supply disruptions.
Additionally, the seasonal transition played a role in maintaining stable demand. As the weather warmed, production activities across several downstream sectors, such as personal care and pharmaceuticals, saw an uptick, which further supported price stability. With an efficient logistics network in place, transportation remained smooth, and deliveries were timely, which contributed to the overall stability of the market.
The price increase can also be attributed to the growing confidence in procurement strategies and the healthy demand from downstream industries. Overall, the European Magnesium Stearate market displayed growth in the first quarter of 2025, in line with trends observed in other regions, indicating a balanced and well-supported market environment.
For the Quarter Ending December 2024
North America
During the entire fourth quarter of 2024, the U.S. Magnesium Stearate market exhibited an upward trend with a steady drop witnessed in the last two months influenced by a mix of supply chain disruptions, seasonal demand shifts, and global factors.
October saw a continued rise in import prices, driven by increased demand for excipients in food and pharmaceutical tablet formulations, combined with higher shipping costs from Asia. U.S. port challenges, particularly in New York, labor strikes, and delays exacerbated logistics issues, further raising costs. Strategic stockpiling and robust export activity, alongside rising feedstock costs for Stearic acid, also added to the price pressure. Additionally, global disruptions in Ukraine, the Middle East, and crude oil prices intensified these price hikes.
In November, import prices trended downward due to increased imports from China, driven by competitive production costs and a weaker yuan, which made Chinese exports more cost-effective. High domestic inventories, lower-than-expected demand from the pharmaceutical and food sectors, and improved logistics contributed to price pressures. However, market sentiment remained cautious as fluctuations in crude oil prices continued to influence production costs.
By December, the market showed a persistent decline in import prices, driven by weak demand from key downstream sectors, including preservatives. Elevated buyer inventories and subdued trading activity, along with increased competition from Chinese imports, contributed to a bearish market outlook for Magnesium Stearate.
Asia Pacific
During the entire fourth quarter of 2024, the Magnesium Stearate market in China experienced notable fluctuations, particularly in China across the Apac region. In October, prices surged due to severe supply constraints and strong demand. A typhoon disrupted shipping operations, causing delays and increasing freight costs, while downstream pharmaceutical and excipient sectors ramped up procurement ahead of seasonal production requirements. The market's pressure intensified due to a limited supply of feed stearic acid, further straining availability. Additionally, the depreciation of the Chinese yuan against the U.S. dollar raised import costs, benefiting traders through improved margins but limiting product availability. Major producers faced reduced stock levels, impacting both domestic and international markets.
By November, however, export prices began to decline as demand from key sectors like pharmaceuticals, personal care, and industrial applications slowed. Despite high feedstock costs, suppliers focused on competitive pricing to counteract diminished foreign orders, leading to aggressive destocking measures that exacerbated the oversupply situation. This oversupply combined with weak downstream absorption capacity drove prices down further. This trend continued until the final weeks of December marking an overall muted trading dynamic. This oversupply situation contributed to a pessimistic market outlook, highlighting the need for strategic actions like production cuts or demand stimulation efforts.
Europe
Germany saw an overall rise in Magnesium Stearate import prices during the fourth quarter of 2024, with a brief decline in November and December. In October, prices increased due to stronger seasonal demand from the food and pharmaceutical sectors, especially for excipient formulations, combined with rising shipping costs from key Asian suppliers. Logistics challenges, including delays at European ports and higher transportation expenses, further raised costs. Supply disruptions in key production regions, coupled with rising Stearic acid prices, added pressure. November saw some price stabilization as imports from China surged, driven by a weakened yuan and competitive production costs. However, demand remained weak, with slow off-takes in the food and pharmaceutical sectors, and high domestic inventories led to oversupply, which exerted downward pressure on prices. Improved logistics and lower freight costs also increased the availability of Magnesium Stearate from Asian suppliers. This trend continued even in December 2024, following persistent weak demand from downstream industries, keeping an overall market trading atmosphere on the southerly side.
For the Quarter Ending September 2024
North America
Throughout Q3 2024, the North American region experienced a significant upward trend in Magnesium Stearate prices, with the USA witnessing the most notable price changes. This increase was influenced by a combination of factors such as rising demand from various industries, limited supply availability, and inflationary pressures. Heightened production costs, particularly for raw materials and energy, combined with logistical disruptions, further exacerbated supply issues. In the U.S., the market exhibited the most pronounced price increases, fueled by strong demand across multiple sectors and anticipatory procurement activity ahead of expected facility closures. Seasonal influences, along with geopolitical tensions and currency fluctuations, further supported this price escalation, boosting the need for various excipients across the food industries, further supporting an overall upward trend. External economic factors, including the depreciation of the US dollar against the exporting nation's currency and increased freight rates, further inflated import costs. Overall, the US witnessed more than a 6% price difference from the previous quarter indicating a significant rise in prices.
Asia Pacific
In Q3 2024, the APAC region, particularly China, witnessed a steady upward trend in Magnesium Stearate prices, driven by several key factors. Resurgent demand across the region, combined with a more positive market sentiment and stable supply levels, created a favorable pricing environment. This demand resurgence was further supported by international buyers seeking higher volumes of Magnesium Stearate, contributing to tightened market conditions and consistent price increases throughout the quarter.China, as a major player in the Magnesium Stearate market, experienced significant price fluctuations, though the overall trajectory remained upward. Supply chain disruptions and limited product availability intensified the supply-demand imbalance, further reinforcing price hikes. Seasonal factors, such as increased procurement ahead of peak usage periods in industries like pharmaceuticals and cosmetics, also contributed to the upward pressure on prices. Comparing Q3 2024 to the previous quarter, China saw a substantial quarter-on-quarter price increase, reflecting broader global market dynamics and strong market performance in the region. With a price rise exceeding 7%, the upward momentum in Magnesium Stearate pricing was evident, signaling robust market activity and a firm outlook for the commodity. The combined effect of internal market factors, including supply constraints, and external influences like global demand growth, shaped the region’s Magnesium Stearate market, positioning it for continued strength in the forthcoming months.
Europe
In Q3 2024, the European market for Magnesium Stearate saw a significant upward trend in pricing, particularly in Germany, where the most pronounced changes occurred. This increase was driven by robust demand across multiple sectors, including pharmaceuticals, food, and cosmetics, coupled with disruptions in the supply chain and plant shutdowns that limited product availability. These factors, combined with rising operational costs and escalating freight charges, intensified pricing pressures across the market. Germany emerged as a focal point for these price hikes, with seasonal demand fluctuations contributing to the trend. As colder months approached, the consumption of excipients, particularly within the food industry, increased, further driving demand for Magnesium Stearate. Additionally, stricter regulatory frameworks and enhanced quality control measures imposed greater costs on imported Magnesium Stearate, further entrenching the upward trajectory in pricing. The appreciation of the Euro against the USD also played a role, creating a more favorable purchasing environment for domestic buyers in Germany, who were better positioned to absorb rising prices. This exchange rate advantage allowed for continued procurement despite the elevated costs, particularly in the pharmaceutical and food industries, where consistent supply is critical. By the end of Q3 2024, Germany stood as a key market reflecting the overall European trend of rising Magnesium Stearate prices, driven by demand growth, supply constraints, and heightened regulatory requirements.
Frequently Asked Questions (FAQs):
1. What is Magnesium Stearate used for in various industries?
Magnesium Stearate is a key lubricant and flow agent used extensively in pharmaceutical tablet and capsule formulations, nutraceutical supplements, food additives, and cosmetic powders. It prevents ingredients from sticking to manufacturing equipment and enhances product uniformity.
2. What are the common grades of Magnesium Stearate available?
The main commercial grades include Pharmaceutical Grade (IP, BP, USP), Food Grade (FCC), and Cosmetic Grade. These vary in terms of purity, microbial control, and source of stearic acid (plant-based vs. animal-based), based on end-use compliance requirements.
3. What factors affect the price of Magnesium Stearate in the global market?
Magnesium Stearate prices are influenced by stearic acid availability, magnesium oxide feedstock trends, regulatory shifts, and demand cycles in pharma and food processing industries. Supply tightness in either base raw material can cause notable price swings.
4. Which countries are the major producers and exporters of Magnesium Stearate?
Key production hubs include China, India, Germany, and the United States. China and India lead in volume production, while Germany often supplies high-purity pharma-grade material. Export patterns depend heavily on regional demand cycles and regulatory alignment.
5. How is Magnesium Stearate regulated for pharma and food applications?
Pharmaceutical and food-grade Magnesium Stearate must comply with regional pharmacopeial standards like USP, EP, or FCC. Manufacturers and buyers must ensure adherence to GMP, BSE/TSE certification, and non-GMO claims where applicable, especially for regulated markets like the U.S. and EU.
